Diabetes in sub-Saharan Africa: from clinical care to health policy

The Lancet Diabetes and Endocrinology

Volumn 5, Issue 8, 2017, Pages 622-667

  Atun, Rifat ^a,b   Davies, Justine I ^c,d   Gale, Edwin A M ^e   Bärnighausen, Till ^a,g,h   Beran, David ^j   Kengne, Andre Pascal ^w   Levitt, Naomi S ^aa   Mangugu, Florence W ^ac   Nyirenda, Moffat J ^p,ah   Ogle, Graham D ^ai,aj   Ramaiya, Kaushik ^an   Sewankambo, Nelson K ^ar   Sobngwi, Eugene ^at   Tesfaye, Solomon ^av   Yudkin, John S ^aw   Basu, Sanjay ⁱ   Bommer, Christian ⁿ   Heesemann, Esther ⁿ   Manne Goehler, Jennifer ^a,b,ad   Postolovska, Iryna ^a   Sagalova, Vera ⁿ   Vollmer, Sebastian ^a,n   Abbas, Zulfiqarali G ^f   Ammon, Benjamin ^a   Angamo, Mulugeta Terekegn ^au   Annamreddi, Akhila ^a   Awasthi, Ananya ^a   Besançon, Stéphane ^k   Bhadriraju, Sudhamayi ^a   Binagwaho, Agnes ^b,l,m   Burgess, Philip I ^o   Burton, Matthew J ^p   Chai, Jeanne ^a   Chilunga, Felix P ^q   Chipendo, Portia ^b   Conn, Anna ^r   Joel, Dipesalema R ^s   Eagan, Arielle W ^t   Gishoma, Crispin ^u   Ho, Julius ^a   Jong, Simcha ^v   Kakarmath, Sujay S ^a   Khan, Yasmin ^x   Kharel, Ramu ^a,y   Kyle, Michael A ^a   Lee, Seitetz C ^a   Lichtman, Amos ^a   Malm, Carl P ^ab   Mbaye, Maïmouna N ^ax   Muhimpundu, Marie A ^ae   Mwagomba, Beatrice M ^af   Mwangi, Kibachio Joseph ^z   Nair, Mohit ^a   Niyonsenga, Simon P ^ae   Njuguna, Benson ^ag   Okafor, Obiageli L O ^a   Okunade, Oluwakemi ^a   Park, Paul H ^ak   Pastakia, Sonak D ^al   Pekny, Chelsea ^am   Reja, Ahmed ^ao   Rotimi, Charles N ^ap   Rwunganira, Samuel ^ae   Sando, David ^a   Sarriera, Gabriela ^aq   Sharma, Anshuman ^a   Sidibe, Assa ^as   Siraj, Elias S ^ay   Syed, Azhra S ^a   Van Acker, Kristien ^a   Werfalli, Mahmoud ^aa   more..

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h AFRICA HEALTH RESEARCH INSTITUTE   (South Africa)

ⁱ STANFORD UNIVERSITY   (United States)

^j GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^k délégation au Mali   (Mali)

^l DARTMOUTH MEDICAL SCHOOL   (United States)

^m UNIVERSITY OF GLOBAL HEALTH EQUITY   (Rwanda)

ⁿ UNIVERSITY OF GÖTTINGEN   (Germany)

^o UNIVERSITY OF LIVERPOOL   (United Kingdom)

^p LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^q KARONGA PREVENTION STUDY   (Malawi)

^r TUFTS UNIVERSITY   (United States)

^s UNIVERSITY OF BOTSWANA   (Botswana)

^t DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^u Rwanda Diabetes Association   (Rwanda)

^v LEIDEN UNIVERSITY   (Netherlands)

^w SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^x JOSLIN DIABETES CENTER   (United States)

^y UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^z MINISTRY OF HEALTH   (Kenya)

^aa UNIVERSITY OF CAPE TOWN   (South Africa)

^ab YALE NEW HAVEN HOSPITAL   (United States)

^ac AGA KHAN UNIVERSITY   (Kenya)

^ad BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^ae RWANDA BIOMEDICAL CENTER   (Rwanda)

^af MINISTRY OF HEALTH   (Malawi)

^ag MOI TEACHING AND REFERRAL HOSPITAL   (Kenya)

^ah MRC UVRI Uganda Research Unit   (Uganda)

^ai International Diabetes Federation Life for a Child Program   (Australia)

^aj Diabetes NSW   (Australia)

^ak PARTNERS IN HEALTH   (United States)

^al PURDUE UNIVERSITY   (United States)

^am OHIO STATE UNIVERSITY   (United States)

^an Shree Hindu Mandal Hospital   (Tanzania)

^ao ADDIS ABABA UNIVERSITY   (Ethiopia)

^ap NATIONAL INSTITUTES OF HEALTH   (United States)

^aq UNIVERSITY OF VERMONT   (United States)

^ar MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^as Hospital du Mali   (Mali)

^at YAOUNDÉ CENTRAL HOSPITAL   (Cameroon)

^au JIMMA UNIVERSITY   (Ethiopia)

^av ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^aw UNIVERSITY COLLEGE LONDON   (United Kingdom)

^ax Service de radiologie   (Senegal)

^ay EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLIBENCLAMIDE; GLICLAZIDE; HUMAN INSULIN; INSULIN; METFORMIN; SULFONYLUREA;

AFRICA SOUTH OF THE SAHARA; AGING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MICROANGIOPATHY; MORTALITY RATE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINA MACULOPATHY; REVIEW; DIABETIC COMPLICATION; RISK FACTOR;

AFRICA SOUTH OF THE SAHARA; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; RISK FACTORS;

EID: 85021794689     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(17)30181-X     Document Type: Review

References (303)

1. WHO. Global report on diabetes, 2016, World Health Organization, Geneva http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf (accessed June 12, 2017).
2. Geldsetzer, P, Barnighausen, T, Late-stage research for diabetes and related NCDs receives little funding: evidence from the NIH RePORTER tool. Lancet Diabetes Endocrinol 5 (2017), 91–92.
3. WHO. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization guideline. Diabetes Res Clin Pract 103 (2014), 341–363.
4. World Bank. FAQs: global poverty line update. http://www.worldbank.org/en/topic/poverty/brief/global-poverty-line-faq, 2015 (accessed March 10, 2017).
5. Riley, L, Guthold, R, Cowan, M, et al. The World Health Organization STEPwise approach to noncommunicable disease risk-factor surveillance: methods, challenges, and opportunities. Am J Public Health 106 (2016), 74–78.
6. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388 (2016), 1459–1544.
7. World Bank. Health nutrition and population statistics. http://data.worldbank.org/data-catalog/health-nutrition-and-population-statistics, 2016 (accessed March 10, 2017).
8. Kengne, AP, June-Rose McHiza, Z, Amoah, AG, Mbanya, JC, Cardiovascular diseases and diabetes as economic and developmental challenges in Africa. Prog Cardiovasc Dis 56 (2013), 302–313.
9. Institute for Health Metrics and Evaluation. Global burden of disease (GBD). http://www.healthdata.org/gbd (accessed March 10, 2017).
10. Levitt, NS, Diabetes in Africa: epidemiology, management and healthcare challenges. Heart 94 (2008), 1376–1382.
11. Manne-Goehler, J, Atun, R, Stokes, A, et al. Diabetes diagnosis and care in sub-Saharan Africa: pooled analysis of individual data from 12 countries. Lancet Diabetes Endocrinol 4 (2016), 903–912.
12. World Bank. World development indicators. http://data.worldbank.org/products/wdi, 2016 (accessed April 27, 2016).
13. Allen, L, Non-communicable disease funding. Lancet Diabetes Endocrinol, 5, 2017, 92.
14. Dieleman, JL, Schneider, MT, Haakenstad, A, et al. Development assistance for health: past trends, associations, and the future of international financial flows for health. Lancet 387 (2016), 2536–2544.
15. UN. High-level meeting on non-communicable diseases. http://www.un.org/en/ga/president/65/issues/ncdiseases.shtml (accessed March 10, 2017).
16. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. Lancet 387 (2016), 1513–1530.
17. Selvin, E, Rawlings, AM, Grams, M, et al. Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol 2 (2014), 279–288.
18. Warren, B, Pankow, JS, Matsushita, K, et al. Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol 5 (2017), 34–42.
19. NCD Risk Factor Collaboration (NCD-RisC). Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331 288 participants. Lancet Diabetes Endocrinol 3 (2015), 624–637.
20. Werfalli, M, Engel, ME, Musekiwa, A, Kengne, AP, Levitt, NS, The prevalence of type 2 diabetes among older people in Africa: a systematic review. Lancet Diabetes Endocrinol 4 (2016), 72–84.
21. Tian, Y, Jiang, C, Wang, M, et al. BMI, leisure-time physical activity, and physical fitness in adults in China: results from a series of national surveys, 2000–14. Lancet Diabetes Endocrinol 4 (2016), 487–497.
22. Zimmet, P, Alberti, KG, Magliano, DJ, Bennett, PH, Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol 12 (2016), 616–622.
23. Bennett, PH, Magliano, DJ, Alberti, KG, Zimmet, P, Liberating non-communicable disease data. Lancet Diabetes Endocrinol 4 (2016), 815–816.
24. Davies, J, Yudkin, JS, Atun, R, Liberating data: the crucial weapon in the fight against NCDs. Lancet Diabetes Endocrinol 4 (2016), 197–198.
25. IDF. IDF Diabetes Atlas, 7th edition, 2015, International Diabetes Federation, Brussels http://www.diabetesatlas.org/ (accessed March 10, 2017).
26. Hall, V, Thomsen, RW, Henriksen, O, Lohse, N, Diabetes in Sub Saharan Africa 1999–2011: epidemiology and public health implications. A systematic review. BMC Public Health, 11, 2011, 564.
27. Scott, A, Ejikeme, CS, Clottey, EN, Thomas, JG, Obesity in sub-Saharan Africa: development of an ecological theoretical framework. Health Promot Int 28 (2013), 4–16.
28. McCarthy, MI, Genomics, type 2 diabetes, and obesity. N Engl J Med 363 (2010), 2339–2350.
29. Helgason, A, Pálsson, S, Thorleifsson, G, et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 39 (2007), 218–225.
30. Adeyemo, AA, Tekola-Ayele, F, Doumatey, AP, et al. Evaluation of genome wide association study associated type 2 diabetes susceptibility loci in sub Saharan Africans. Front Genet, 6, 2015, 335.
31. Yako, YY, Guewo-Fokeng, M, Balti, EV, et al. Genetic risk of type 2 diabetes in populations of the African continent: a systematic review and meta-analyses. Diabetes Res Clin Pract 114 (2016), 136–150.
32. Corona, E, Mapping genetic risk of disease across the world. http://geneworld.erikcorona.com/geneworld, 2016 (accessed March 10, 2017).
33. Marshall, MC Jr, Diabetes in African Americans. Postgrad Med J 81 (2005), 734–740.
34. CDC. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011, US Department of Health and Human Services, Atlanta.
35. Zimmet, PZ, Magliano, DJ, Herman, WH, Shaw, JE, Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol 2 (2014), 56–64.
36. Noble, JA, Johnson, J, Lane, JA, Valdes, AM, HLA class II genotyping of African American type 1 diabetic patients reveals associations unique to African haplotypes. Diabetes 62 (2013), 3292–3299.
37. Mbanya, JCN, Motala, AA, Sobngwi, E, Assah, FK, Enoru, ST, Diabetes in sub-Saharan Africa. Lancet 375 (2010), 2254–2266.
38. Kengne, AP, Echouffo-Tcheugui, JB, Sobngwi, E, Mbanya, JC, New insights on diabetes mellitus and obesity in Africa—part 1: prevalence, pathogenesis and comorbidities. Heart 99 (2013), 979–983.
39. O'Hara, EG, Nuche-Berenguer, B, Kirui, NK, et al. Diabetes in rural Africa: what can Kenya show us?. Lancet Diabetes Endocrinol 4 (2016), 807–809.
40. NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet 387 (2016), 1377–1396.
41. Monteiro, CA, D'A Benicio, MH, Conde, WL, Popkin, BM, Shifting obesity trends in Brazil. Eur J Clin Nutr 54 (2000), 342–346.
42. Ziraba, AK, Fotso, JC, Ochako, R, Overweight and obesity in urban Africa: a problem of the rich or the poor?. BMC Public Health, 9, 2009, 465.
43. Popkin, BM, Adair, LS, Ng, SW, Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev 70 (2012), 3–21.
44. IFAD. Structural and rural transformation in Africa. Rural Development Report 2016, 2016, Quintily, Rome.
45. Pampel, FC, Denney, JT, Krueger, PM, Obesity, SES, and economic development: a test of the reversal hypothesis. Soc Sci Med 74 (2012), 1073–1081.
46. Aitsi-Selmi, A, Bell, R, Shipley, MJ, Marmot, MG, Education modifies the association of wealth with obesity in women in middle-income but not low-income countries: an interaction study using seven national datasets, 2005–2010. PLoS One, 9, 2014, e90403.
47. Murphy, GA, Asiki, G, Ekoru, K, et al. Sociodemographic distribution of non-communicable disease risk factors in rural Uganda: a cross-sectional study. Int J Epidemiol 42 (2013), 1740–1753.
48. Gillman, MW, Prenatal famine and developmental origins of type 2 diabetes. Lancet Diabetes Endocrinol 3 (2015), 751–752.
49. Lelijveld, N, Seal, A, Wells, JC, et al. Chronic disease outcomes after severe acute malnutrition in Malawian children (ChroSAM): a cohort study. Lancet Glob Health 4 (2016), e654–e662.
50. Gill, GV, Mbanya, JC, Ramaiya, KL, Tesfaye, S, A sub-Saharan African perspective of diabetes. Diabetologia 52 (2009), 8–16.
51. UN Department of Economic and Social Affairs, Population Division. World fertility report 2013: fertility at the extremes. http://www.un.org/en/development/desa/population/publications/pdf/fertility/worldFertilityReport2013.pdf, 2014 (accessed March 10, 2017).
52. Geldsetzer, P, Manne-Goehler, J, Bärnighausen, T, Davies, JI, What research is needed to address the co-epidemics of HIV and cardiometabolic disease in sub-Saharan Africa?. Lancet Diabetes Endocrinol, 2017, 10.1016/S2213-8587(17)30091-8 published online March 17.
53. Alemu, S, Dessie, A, Seid, E, et al. Insulin-requiring diabetes in rural Ethiopia: should we reopen the case for malnutrition-related diabetes?. Diabetologia 52 (2009), 1842–1845.
54. Gale, EAM, The rise of childhood type 1 diabetes in the 20th century. Diabetes 51 (2002), 3353–3361.
55. Zung, A, Elizur, M, Weintrob, N, et al. Type 1 diabetes in Jewish Ethiopian immigrants in Israel: HLA class II immunogenetics and contribution of new environment. Hum Immunol 65 (2004), 1463–1468.
56. Marshall, SL, Edidin, D, Sharma, V, Ogle, G, Arena, VC, Orchard, T, Current clinical status, glucose control, and complication rates of children and youth with type 1 diabetes in Rwanda. Pediatr Diabetes 14 (2013), 217–226.
57. Karvonen, M, Viik-Kajander, M, Moltchanova, E, Libman, I, LaPorte, R, Tuomilehto, J, Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 23 (2000), 1516–1526.
58. Piloya-Were, T, Sunni, M, Ogle, GD, Moran, A, Childhood diabetes in Africa. Curr Opin Endocrinol Diabetes Obes 23 (2016), 306–311.
59. Rwiza, HT, Swai, ABM, McLarty, DG, Failure to diagnose diabetic ketoacidosis in Tanzania. Diabet Med 3 (1986), 181–183.
60. Ogle, GD, Middlehurst, AC, Silink, M, The IDF Life for a Child Program Index of diabetes care for children and youth. Pediatr Diabetes 17 (2016), 374–384.
61. Marshall, SL, Edidin, D, Arena, VC, et al. Prevalence and incidence of clinically recognized cases of type 1 diabetes in children and adolescents in Rwanda, Africa. Diabet Med 32 (2015), 1186–1192.
62. 1c based, care and education. Diabetes Res Clin Pract 107 (2015), 113–122.
63. Umpierrez, GE, Smiley, D, Kitabchi, AE, Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med 144 (2006), 350–357.
64. Ma, RCW, Schmidt, MI, Tam, WH, McIntyre, HD, Catalano, PM, Clinical management of pregnancy in the obese mother: before conception, during pregnancy, and post partum. Lancet Diabetes Endocrinol 4 (2016), 1037–1049.
65. Poston, L, Caleyachetty, R, Cnattingius, S, et al. Preconceptional and maternal obesity: epidemiology and health consequences. Lancet Diabetes Endocrinol 4 (2016), 1025–1036.
66. World Obesity Federation. World map of obesity. http://www.worldobesity.org/resources/world-map-obesity, 2015 (accessed March 10, 2017).
67. Macaulay, S, Dunger, DB, Norris, SA, Gestational diabetes mellitus in Africa: a systematic review. PLoS One, 9, 2014, e97871.
68. Olagbuji, BN, Atiba, AS, Olofinbiyi, BA, et al., for the Gestational Diabetes Study Group—Nigeria. Prevalence of and risk factors for gestational diabetes using 1999, 2013 WHO and IADPSG criteria upon implementation of a universal one-step screening and diagnostic strategy in a sub-Saharan African population. Eur J Obstet Gynecol Reprod Biol 189 (2015), 27–32.
69. WHO, Department of Noncommunicable Disease Surveillance. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1, Diagnosis and classification of diabetes mellitus, 1999, World Health Organization, Geneva.
70. Colagiuri, S, Falavigna, M, Agarwal, MM, et al. Strategies for implementing the WHO diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Diabetes Res Clin Pract 103 (2014), 364–372.
71. Metzger, BE, Gabbe, SG, Persson, B, et al., for the International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33 (2010), 676–682.
72. Metzger, BE, Lowe, LP, Dyer, AR, et al., for the HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358 (2008), 1991–2002.
73. Farrar, D, Fairley, L, Santorelli, G, et al. Association between hyperglycaemia and adverse perinatal outcomes in south Asian and white British women: analysis of data from the Born in Bradford cohort. Lancet Diabetes Endocrinol 3 (2015), 795–804.
74. Hedderson, M, Ehrlich, S, Sridhar, S, Darbinian, J, Moore, S, Ferrara, A, Racial/ethnic disparities in the prevalence of gestational diabetes mellitus by BMI. Diabetes Care 35 (2012), 1492–1498.
75. Morrison, JL, Hodgson, LAB, Lim, LL, Al-Qureshi, S, Diabetic retinopathy in pregnancy: a review. Clin Experiment Ophthalmol 44 (2016), 321–334.
76. Inkster, ME, Fahey, TP, Donnan, PT, Leese, GP, Mires, GJ, Murphy, DJ, Poor glycated haemoglobin control and adverse pregnancy outcomes in type 1 and type 2 diabetes mellitus: systematic review of observational studies. BMC Pregnancy Childbirth, 6, 2006, 30.
77. Fraser, RB, The fate of the pregnant diabetic in the developing country: Kenya. Diabetologia 22 (1982), 21–24.
78. Huddle, KR, Audit of the outcome of pregnancy in diabetic women in Soweto, South Africa, 1992–2002. S Afr Med J 95 (2005), 789–794.
79. Zeck, W, McIntyre, HD, Gestational diabetes in rural East Africa: a call to action. J Womens Health (Larchmt) 17 (2008), 403–411.
80. Coetzee, EJ, Jackson, WPU, The management of non-insulin-dependent diabetes during pregnancy. Diabetes Res Clin Pract 1 (1985–1986), 281–287.
81. Gill, GV, Huddle, KRL, Monkoe, G, Long-term (20 years) outcome and mortality of type 1 diabetic patients in Soweto, South Africa. Diabet Med 22 (2005), 1642–1646.
82. Ekpebegh, CO, Coetzee, EJ, van der Merwe, L, Levitt, NS, A 10-year retrospective analysis of pregnancy outcome in pregestational type 2 diabetes: comparison of insulin and oral glucose-lowering agents. Diabet Med 24 (2007), 253–258.
83. WHO. National capacity to address and respond to NCDs: existence of operational policies, strategies, or action plans. http://www.who.int/gho/ncd/health_system_response/policy_text/en, 2016 (accessed March 10, 2017).
84. Riza, AL, Pearson, F, Ugarte-Gil, C, et al. Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol 2 (2014), 740–753.
85. van Crevel, R, van de Vijver, S, Moore, DAJ, The global diabetes epidemic: what does it mean for infectious diseases in tropical countries?. Lancet Diabet Endocrinol 5 (2016), 457–468.
86. Pearson-Stuttard, J, Blundell, S, Harris, T, Cook, DG, Critchley, J, Diabetes and infection: assessing the association with glycaemic control in population-based studies. Lancet Diabetes Endocrinol 4 (2016), 148–158.
87. Nou, E, Lo, J, Hadigan, C, Grinspoon, SK, Pathophysiology and management of cardiovascular disease in patients with HIV. Lancet Diabetes Endocrinol 4 (2016), 598–610.
88. Sankoh, O, Byass, P, Cause-specific mortality at INDEPTH Health and Demographic Surveillance System Sites in Africa and Asia: concluding synthesis. Glob Health Action, 7, 2014, 25590.
89. I SATHL-AIDMTAC. Le diabète juvénile au Mali. Rev Fr Endocrinol Clin 40 (1999), 513–521.
90. Beran, D, Yudkin, JS, de Courten, M, Access to care for patients with insulin-requiring diabetes in developing countries: case studies of Mozambique and Zambia. Diabetes Care 28 (2005), 2136–2140.
91. Livingstone, SJ, Levin, D, Looker, HC, et al. for the Scottish Diabetes Research Network epidemiology group, the Scottish Renal Registry. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008–2010. JAMA 313 (2015), 37–44.
92. Bertram, MY, Jaswal, AV, Van Wyk, VP, Levitt, NS, Hofman, KJ, The non-fatal disease burden caused by type 2 diabetes in South Africa, 2009. Glob Health Action, 6, 2013, 19244.
93. Cheung, N, Mitchell, P, Wong, TY, Diabetic retinopathy. Lancet 376 (2010), 124–136.
94. Bourne, RR, Stevens, GA, White, RA, et al., for the Vision Loss Expert Group. Causes of vision loss worldwide, 1990–2010: a systematic analysis. Lancet Glob Health 1 (2013), e339–e349.
95. Burgess, PI, MacCormick, IJC, Harding, SP, Bastawrous, A, Beare, NAV, Garner, P, Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review. Diabet Med 30 (2013), 399–412.
96. Lee, R, Wong, TY, Sabanayagam, C, Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis, 2, 2015, 17.
97. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol 2 (2014), 634–647.
98. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386 (2015), 743–800.
99. Stanifer, JW, Jing, B, Tolan, S, et al. The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Glob Health 2 (2014), e174–e181.
100. Lancet Diabetes Endocrinology. Diabetic kidney disease: what does the next era hold?. Lancet Diabetes Endocrinol, 3, 2015, 665.
101. Noubiap, JJ, Naidoo, J, Kengne, AP, Diabetic nephropathy in Africa: a systematic review. World J Diabetes 6 (2015), 759–773.
102. Genovese, G, Friedman, DJ, Ross, MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329 (2010), 841–845.
103. Breyer M. Faculty of 1000 evaluation for association of trypanolytic ApoL1 variants with kidney disease in African Americans. F1000—Post-publication peer review of the biomedical literature: Faculty of 1000, Ltd.
104. Osafo, C, Raji, YR, Olanrewaju, T, et al., for the H3Africa Kidney Disease Research Network. Genomic approaches to the burden of kidney disease in Sub-Saharan Africa: the Human Heredity and Health in Africa (H3Africa) Kidney Disease Research Network. Kidney Int 90 (2016), 2–5.
105. Abbas, ZG, The global burden of diabetic foot. Pendsey, S, (eds.) Contemporary management of the diabetic foot, 2014, Jaypee Brothers Medical Publishers, New Delhi, 24–30.
106. Margolis, DJ, Malay, DS, Hoffstad, OJ, et al. Prevalence of diabetes, diabetic foot ulcer, and lower extremity amputation among Medicare beneficiaries, 2006 to 2008, 2011, Data Points Publication Series.
107. Bakker, K, Apelqvist, J, Lipsky, BA, Van Netten, JJ, for the International Working Group on the Diabetic Foot. The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence-based global consensus. Diabetes Metab Res Rev 32:suppl 1 (2016), 2–6.
108. Cockburn, N, Steven, D, Lecuona, K, et al. Prevalence, causes and socio-economic determinants of vision loss in Cape Town, South Africa. PLoS One, 7, 2012, e30718.
109. Abbas, ZG, Lutale, JK, Bakker, K, Baker, N, Archibald, LK, The ‘Step by Step’ Diabetic Foot Project in Tanzania: a model for improving patient outcomes in less-developed countries. Int Wound J 8 (2011), 169–175.
110. Ndip, EA, Tchakonte, B, Mbanya, JC, A study of the prevalence and risk factors of foot problems in a population of diabetic patients in Cameroon. Int J Low Extrem Wounds 5 (2006), 83–88.
111. Ogbera, AO, Fasanmade, O, Ohwovoriole, AE, Adediran, O, An assessment of the disease burden of foot ulcers in patients with diabetes mellitus attending a teaching hospital in Lagos, Nigeria. Int J Low Extrem Wounds 5 (2006), 244–249.
112. Tesfaye, S, Boulton, AJM, Dyck, PJ, et al., for the Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33 (2010), 2285–2293.
113. Abbas, ZG, Archibald, LK, Challenges for management of the diabetic foot in Africa: doing more with less. Int Wound J 4 (2007), 305–313.
114. Abbas, ZG, Lutale, JK, Archibald, LK, Diabetic foot ulcers and ethnicity in Tanzania: a contrast between African and Asian populations. Int Wound J 6 (2009), 124–131.
115. Jeffcoate, WJ, Harding, KG, Diabetic foot ulcers. Lancet 361 (2003), 1545–1551.
116. Levitt, NS, Bradshaw, D, Zwarenstein, MF, Bawa, AA, Maphumolo, S, Audit of public sector primary diabetes care in Cape Town, South Africa: high prevalence of complications, uncontrolled hyperglycaemia, and hypertension. Diabet Med 14 (1997), 1073–1077.
117. Okello, S, Millard, A, Owori, R, et al. Prevalence of lower extremity peripheral artery disease among adult diabetes patients in southwestern Uganda. BMC Cardiovasc Disord, 14, 2014, 75.
118. Kumar, A, Mash, B, Rupesinghe, G, Peripheral arterial disease—high prevalence in rural black South Africans. S Afr Med J 97 (2007), 285–288.
119. Abbas, ZG, Lutale, J, Archibald, LK, Rodent bites on the feet of diabetes patients in Tanzania. Diabet Med 22 (2005), 631–633.
120. Dunbar, GL, Hellenberg, DA, Levitt, NS, Diabetes mellitus and non-traumatic lower extremity amputations in four public sector hospitals in Cape Town, South Africa, during 2009 and 2010. S Afr Med J 105 (2015), 1053–1056.
121. Gulam-Abbas, Z, Lutale, JK, Morbach, S, Archibald, LK, Clinical outcome of diabetes patients hospitalized with foot ulcers, Dar es Salaam, Tanzania. Diabet Med 19 (2002), 575–579.
122. Lam, C, Martinson, N, Hepp, L, et al. Prevalence of tobacco smoking in adults with tuberculosis in South Africa. Int J Tuberc Lung Dis 17 (2013), 1354–1357.
123. Waweru, P, Anderson, R, Steel, H, Venter, WD, Murdoch, D, Feldman, C, The prevalence of smoking and the knowledge of smoking hazards and smoking cessation strategies among HIV-positive patients in Johannesburg, South Africa. S Afr Med J 103 (2013), 858–860.
124. Gaziano, TA, Cardiovascular disease in the developing world and its cost-effective management. Circulation 112 (2005), 3547–3553.
125. Addo, J, Smeeth, L, Leon, DA, Hypertension in sub-Saharan Africa: a systematic review. Hypertension 50 (2007), 1012–1018.
126. Gudina, EK, Amade, ST, Tesfamichael, FA, Ram, R, Assessment of quality of care given to diabetic patients at Jimma University Specialized Hospital diabetes follow-up clinic, Jimma, Ethiopia. BMC Endocr Disord, 11, 2011, 19.
127. Adeniyi, OV, Yogeswaran, P, Longo-Mbenza, B, Ter Goon, D, Uncontrolled hypertension and its determinants in patients with concomitant type 2 diabetes mellitus (T2DM) in rural South Africa. PLoS One, 11, 2016, e0150033.
128. Sobngwi, E, Ndour-Mbaye, M, Boateng, KA, et al. Type 2 diabetes control and complications in specialised diabetes care centres of six sub-Saharan African countries: the Diabcare Africa study. Diabetes Res Clin Pract 95 (2012), 30–36.
129. Kengne, AP, Sobngwi, E, Echouffo-Tcheugui, JB, Mbanya, JC, New insights on diabetes mellitus and obesity in Africa—Part 2: prevention, screening and economic burden. Heart 99 (2013), 1072–1077.
130. Kengne, AP, Limen, SN, Sobngwi, E, Djouogo, CF, Nouedoui, C, Metabolic syndrome in type 2 diabetes: comparative prevalence according to two sets of diagnostic criteria in sub-Saharan Africans. Diabetol Metab Syndr, 4, 2012, 22.
131. Hertz, JT, Reardon, JM, Rodrigues, CG, et al. Acute myocardial infarction in sub-Saharan Africa: the need for data. PLoS One, 9, 2014, e96688.
132. Kengne, AP, Amoah, AG, Mbanya, JC, Cardiovascular complications of diabetes mellitus in sub-Saharan Africa. Circulation 112 (2005), 3592–3601.
133. Feigin, VL, Lawes, CMM, Bennett, DA, Barker-Collo, SL, Parag, V, Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 8 (2009), 355–369.
134. Lekoubou, A, Nkoke, C, Dzudie, A, Kengne, AP, Stroke admission and case-fatality in an urban medical unit in sub-Saharan Africa: a fourteen year trend study from 1999 to 2012. J Neurol Sci 350 (2015), 24–32.
135. Echouffo-Tcheugui, JB, Dzudie, A, Epacka, ME, et al. Prevalence and determinants of undiagnosed diabetes in an urban sub-Saharan African population. Prim Care Diabetes 6 (2012), 229–234.
136. American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes Care 37:suppl 1 (2014), S14–S80.
137. American Diabetes Association. Standards of medical care in diabetes—2017: summary of revisions. Diabetes Care 40:suppl 1 (2017), S4–S5.
138. World Bank. Service Delivery Indicators. http://datatopics.worldbank.org/sdi (accessed March 10, 2017).
139. Beran, D, Yudkin, JS, Looking beyond the issue of access to insulin: what is needed for proper diabetes care in resource poor settings. Diabetes Res Clin Pract 88 (2010), 217–221.
140. Swai, AB, Lyimo, PJ, Rutayuga, F, McLarty, DG, Diabetes mellitus misdiagnosed as AIDS. Lancet, 2, 1989, 976.
141. Makani, J, Matuja, W, Liyombo, E, Snow, RW, Marsh, K, Warrell, DA, Admission diagnosis of cerebral malaria in adults in an endemic area of Tanzania: implications and clinical description. QJM 96 (2003), 355–362.
142. Majaliwa, ES, Munubhi, E, Ramaiya, K, et al. Survey on acute and chronic complications in children and adolescents with type 1 diabetes at Muhimbili National Hospital in Dar es Salaam, Tanzania. Diabetes Care 30 (2007), 2187–2192.
143. Folb, N, Timmerman, V, Levitt, NS, et al. Multimorbidity, control and treatment of noncommunicable diseases among primary healthcare attenders in the Western Cape, South Africa. S Afr Med J 105 (2015), 642–647.
144. Mash, RJ, Rhode, H, Zwarenstein, M, et al. Effectiveness of a group diabetes education programme in under-served communities in South Africa: a pragmatic cluster randomized controlled trial. Diabet Med 31 (2014), 987–993.
145. Chinenye, S, Uloko, AE, Ogbera, AO, et al. Profile of Nigerians with diabetes mellitus—Diabcare Nigeria study group (2008): results of a multicenter study. Indian J Endocrinol Metab 16 (2012), 558–564.
146. Ogle, GD, Kim, H, Middlehurst, AC, Silink, M, Jenkins, AJ, Financial costs for families of children with type 1 diabetes in lower-income countries. Diabet Med 33 (2016), 820–826.
147. Spurling, GK, Mansfield, PR, Montgomery, BD, et al. Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review. PLoS Med, 7, 2010, e1000352.
148. Wu, JHY, Foote, C, Blomster, J, et al. Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 4 (2016), 411–419.
149. Beran, D, Ewen, M, Laing, R, Constraints and challenges in access to insulin: a global perspective. Lancet Diabetes Endocrinol 4 (2016), 275–285.
150. Ogle, GD, Abdullah, M, Mason, D, Januszewski, AS, Besançon, S, Insulin storage in hot climates without refrigeration: temperature reduction efficacy of clay pots and other techniques. Diabet Med 33 (2016), 1544–1553.
151. Majaliwa, ES, Elusiyan, BE, Adesiyun, OO, et al. Type 1 diabetes mellitus in the African population: epidemiology and management challenges. Acta Biomed 79 (2008), 255–259.
152. Basu, S, Shankar, V, Yudkin, JS, Comparative effectiveness and cost-effectiveness of treat-to-target versus benefit-based tailored treatment of type 2 diabetes in low-income and middle-income countries: a modelling analysis. Lancet Diabetes Endocrinol 4 (2016), 922–932.
153. Gaede, P, Lund-Andersen, H, Parving, HH, Pedersen, O, Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358 (2008), 580–591.
154. Werner, ME, van de Vijver, S, Adhiambo, M, Egondi, T, Oti, SO, Kyobutungi, C, Results of a hypertension and diabetes treatment program in the slums of Nairobi: a retrospective cohort study. BMC Health Serv Res, 15, 2015, 512.
155. Adedeji, AR, Tumbo, J, Govender, I, Adherence of doctors to a clinical guideline for hypertension in Bojanala district, North-West Province, South Africa. Afr J Prim Health Care Fam Med, 7, 2015, 776.
156. Kengne, AP, Njamnshi, AK, Mbanya, JC, Cardiovascular risk reduction in diabetes in sub-Saharan Africa: what should the priorities be in the absence of global risk evaluation tools?. Clin Med Insights Cardiol 2 (2008), 25–31.
157. Ataklte, F, Erqou, S, Kaptoge, S, Taye, B, Echouffo-Tcheugui, JB, Kengne, AP, Burden of undiagnosed hypertension in sub-Saharan Africa: a systematic review and meta-analysis. Hypertension 65 (2015), 291–298.
158. Yusuf, S, Wood, D, Ralston, J, Reddy, KS, The World Heart Federation's vision for worldwide cardiovascular disease prevention. Lancet 386 (2015), 399–402.
159. Cleland, CR, Burton, MJ, Hall, C, et al. Diabetic retinopathy screening: experiences from northern Tanzania. Lancet Diabetes Endocrinol 4 (2016), 10–12.
160. Cleland, CR, Burton, MJ, Hall, C, et al. Diabetic retinopathy in Tanzania: prevalence and risk factors at entry into a regional screening programme. Trop Med Int Health 21 (2016), 417–426.
161. Burgess, PI, Msukwa, G, Beare, NAV, Diabetic retinopathy in sub-Saharan Africa: meeting the challenges of an emerging epidemic. BMC Med, 11, 2013, 157.
162. Matimba, A, Woodward, R, Tambo, E, Ramsay, M, Gwanzura, L, Guramatunhu, S, Tele-ophthalmology: opportunities for improving diabetes eye care in resource- and specialist-limited sub-Saharan African countries. J Telemed Telecare 22 (2016), 311–316.
163. Bastawrous, A, Rono, HK, Livingstone, IAT, et al. Development and validation of a smartphone-based visual acuity test (peek acuity) for clinical practice and community-based fieldwork. JAMA Ophthalmol 133 (2015), 930–937.
164. Naicker, S, Burden of end-stage renal disease in sub-Saharan Africa. Clin Nephrol 74:suppl 1 (2010), S13–S16.
165. Das, P, Horton, R, Physical activity—time to take it seriously and regularly. Lancet 388 (2016), 1254–1255.
166. Griffin, SJ, Borch-Johnsen, K, Davies, MJ, et al. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet 378 (2011), 156–167.
167. Durão, S, Ajumobi, O, Kredo, T, et al. Evidence insufficient to confirm the value of population screening for diabetes and hypertension in low- and-middle-income settings. S Afr Med J 105 (2015), 98–102.
168. Echouffo-Tcheugui, JB, Mayige, M, Ogbera, AO, Sobngwi, E, Kengne, AP, Screening for hyperglycemia in the developing world: rationale, challenges and opportunities. Diabetes Res Clin Pract 98 (2012), 199–208.
169. Dalal, S, Beunza, JJ, Volmink, J, et al. Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol 40 (2011), 885–901.
170. Atun, R, Aydın, S, Chakraborty, S, et al. Universal health coverage in Turkey: enhancement of equity. Lancet 382 (2013), 65–99.
171. WHO. Global Health Observatory country views. http://apps.who.int/gho/data/node.country, 2016 (accessed March 10, 2017).
172. WHO. Global Health Observatory data repository. Polices, strategies, and action plans: data by country. http://apps.who.int/gho/data/node.main.A907?lang=en, 2016 (accessed April 13, 2016).
173. Meheus, F, McIntyre, D, Fiscal space for domestic funding of health and other social services. Health Econ Policy Law 12 (2017), 159–177.
174. UN. Abuja declaration on HIV/AIDS, tuberculosis, and other infectious diseases. http://www.un.org/ga/aids/pdf/abuja_declaration.pdf, 2001 (accessed June 12, 2017).
175. Huffman, MD, Rao, KD, Pichon-Riviere, A, et al. A cross-sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low- and middle-income countries. PLoS One, 6, 2011, e20821.
176. Wang, Q, Brenner, S, Leppert, G, Banda, TH, Kalmus, O, De Allegri, M, Health seeking behaviour and the related household out-of-pocket expenditure for chronic non-communicable diseases in rural Malawi. Health Policy Plan 30 (2015), 242–252.
177. Wang, Q, Fu, AZ, Brenner, S, Kalmus, O, Banda, HT, De Allegri, M, Out-of-pocket expenditure on chronic non-communicable diseases in sub-Saharan Africa: the case of rural Malawi. PLoS One, 10, 2015, e0116897.
178. Global Health Workforce Allicance, WHO. A universal truth: no health without a workforce, 2013, World Health Organization, Geneva.
179. Mullan, F, Frehywot, S, Omaswa, F, et al. Medical schools in sub-Saharan Africa. Lancet 377 (2011), 1113–1121.
180. Scheffler, RM, Mahoney, CB, Fulton, BD, Dal Poz, MR, Preker, AS, Estimates of health care professional shortages in sub-Saharan Africa by 2015. Health Aff 28 (2009), w849–w862.
181. Mullan, F, Frehywot, S, Non-physician clinicians in 47 sub-Saharan African countries. Lancet 370 (2007), 2158–2163.
182. Celletti, F, Wright, A, Palen, J, et al. Can the deployment of community health workers for the delivery of HIV services represent an effective and sustainable response to health workforce shortages? Results of a multicountry study. AIDS 24:suppl 1 (2010), S45–S57.
183. Mwai, GW, Mburu, G, Torpey, K, Frost, P, Ford, N, Seeley, J, Role and outcomes of community health workers in HIV care in sub-Saharan Africa: a systematic review. J Int AIDS Soc, 16, 2013, 18586.
184. WHO. Service Availability and Readiness Assessment (SARA). http://www.who.int/healthinfo/systems/sara_methods/en (accessed March 10, 2017).
185. Beran, D, Silva Matos, C, Yudkin, JS, The Diabetes UK Mozambique Twinning Programme. Results of improvements in diabetes care in Mozambique: a reassessment 6 years later using the Rapid Assessment Protocol for Insulin Access. Diabet Med 27 (2010), 855–861.
186. Bowser, D, Sparkes, SP, Mitchell, A, et al. Global Fund investments in human resources for health: innovation and missed opportunities for health systems strengthening. Health Policy Plan 29 (2014), 986–997.
187. WHO. WHO global action plan for the prevention and control of NCDs 2013–2020, 2013, World Health Organization, Geneva.
188. Peck, R, Mghamba, J, Vanobberghen, F, et al. Preparedness of Tanzanian health facilities for outpatient primary care of hypertension and diabetes: a cross-sectional survey. Lancet Glob Health 2 (2014), e285–e292.
189. Cameron, A, Ewen, M, Ross-Degnan, D, Ball, D, Laing, R, Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 373 (2009), 240–249.
190. Mendis, S, Fukino, K, Cameron, A, et al. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ 85 (2007), 279–288.
191. Kaplan, W, Sharma, A, Kolaczyk, E, Shappell, H, Insulin trade profile. http://haiweb.org/wp-content/uploads/2016/06/ACCISS-TradeReport_FINAL_2.pdf, April 2016 (accessed April 10, 2016).
192. MSH. International medical products price guide. http://erc.msh.org/mainpage.cfm?file=1.0.htm&module=dmp&language=english, 2015 (accessed March 10, 2017).
193. Ewen, M, Joosse, H-J, Ashigbie, P, Beran, D, Laing, R, Insulin prices profile. http://haiweb.org/wp-content/uploads/2016/04/ACCISS-Prices-report_FINAL-1.pdf, April 2016 (accessed April 10, 2016).
194. WHO. Drugs used in diabetes. http://www.whocc.no/atc_ddd_index/?code=A10A, 2013 (accessed March 10, 2017).
195. World Bank. PovcalNet: an online analysis tool for global poverty monitoring. http://iresearch.worldbank.org/PovcalNet/home.aspx (accessed June 23, 2017).
196. World Bank. Uganda—Service Delivery Indicators Health Survey 2013—harmonized public use data. http://microdata.worldbank.org/index.php/catalog/2750/sampling (accessed June 10, 2017).
197. Tudor Car, L, Brusamento, S, Elmoniry, H, et al. The uptake of integrated perinatal prevention of mother-to-child HIV transmission programs in low- and middle-income countries: a systematic review. PLoS One, 8, 2013, e56550.
198. Haber, N, Pillay, D, Porter, K, Bärnighausen, T, Constructing the cascade of HIV care: methods for measurement. Curr Opin HIV AIDS 11 (2016), 102–108.
199. Ali, MK, Bullard, KM, Gregg, EW, Del Rio, C, A cascade of care for diabetes in the United States: visualizing the gaps. Ann Intern Med 161 (2014), 681–689.
200. WHO. The STEPS instrument and support materials. http://www.who.int/chp/steps/instrument/en, 2015 (accessed March 10, 2017).
201. Ministry of Health and Social Services, Namibia Statistics Agency. Namibia demographic and health survey 2013. https://dhsprogram.com/pubs/pdf/FR298/FR298.pdf, 2014 (accessed March 10, 2017).
202. Labadarios, D, Shisana, O, Rehle, T, Simbayi, L, SANHANES: a unique survey series in the health landscape. S Afr Med J 104 (2014), 675–676.
203. Atun, R, Gale, EAM, The challenge of diabetes in sub-Saharan Africa. Lancet Diabetes Endocrinol 3 (2015), 675–677.
204. Bommer, C, Heesemann, E, Sagalova, V, et al. The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study. Lancet Diabetes Endocrinol 5 (2017), 423–430.
205. Chale, SS, Swai, AB, Mujinja, PG, McLarty, DG, Must diabetes be a fatal disease in Africa? Study of costs of treatment. BMJ 304 (1992), 1215–1218.
206. Nkegoum AV. Coût direct et indirect du diabéte en l'absence de complications chroniques à Yaoundé, Cameroun. MD thesis, University of Yaoundé I, 2002.
207. Minor, T, An investigation into the effect of type I and type II diabetes duration on employment and wages. Econ Hum Biol 11 (2013), 534–544.
208. Loeppke, R, Taitel, M, Haufle, V, Parry, T, Kessler, RC, Jinnett, K, Health and productivity as a business strategy: a multiemployer study. J Occup Environ Med 51 (2009), 411–428.
209. Seuring, T, Goryakin, Y, Suhrcke, M, The impact of diabetes on employment in Mexico. Econ Hum Biol 18 (2015), 85–100.
210. Seuring, T, Serneels, P, Suhrcke, ME, The impact of diabetes on labour market outcomes in Mexico: a panel data and biomarker analysis, 2016, Centre for Health Economics, University of York, York.
211. Yang, W, Dall, TM, Halder, P, Gallo, P, Kowal, SL, Hogan, PF, for the American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36 (2013), 1033–1046.
212. Sharma, KM, Ranjani, H, Zabetian, A, et al. Excess cost burden of diabetes in southern India: a clinic-based, comparative cost-of-illness study. Global Health Epidemiol Genom, 1, 2016, e8.
213. Esteghamati, A, Khalilzadeh, O, Anvari, M, et al. The economic costs of diabetes: a population-based study in Tehran, Iran. Diabetologia 52 (2009), 1520–1527.
214. Guariguata, L, de Beer, I, Hough, R, et al. Diabetes, HIV and other health determinants associated with absenteeism among formal sector workers in Namibia. BMC Public Health, 12, 2012, 44.
215. Kirigia, JM, Sambo, HB, Sambo, LG, Barry, SP, Economic burden of diabetes mellitus in the WHO African region. BMC Int Health Hum Rights, 9, 2009, 6.
216. UN Department of Economic and Social Affairs, Population Division. The World population prospects: the 2015 revision. 2015. CD-ROM edition.
217. UN Department of Economic and Social Affairs, Population Division. World urbanization prospects: the 2014 revision. CD-ROM edn, 2014.
218. Assah, FK, Ekelund, U, Brage, S, Mbanya, JC, Wareham, NJ, Urbanization, physical activity, and metabolic health in sub-Saharan Africa. Diabetes Care 34 (2011), 491–496.
219. OECD. Input costs for health care provision. https://stats.oecd.org/Index.aspx?DataSetCode=SHA_FP (accessed June 23, 2017).
220. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317 (1998), 703–713.
221. Duckworth, W, Abraira, C, Moritz, T, for the VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360 (2009), 129–139.
222. Sussman, J, Vijan, S, Hayward, R, Using benefit-based tailored treatment to improve the use of antihypertensive medications. Circulation 128 (2013), 2309–2317.
223. Basu, S, Yudkin, JS, Sussman, JB, Millett, C, Hayward, RA, Alternative strategies to achieve cardiovascular mortality goals in China and India: a microsimulation of target- versus risk-based blood pressure treatment. Circulation 133 (2016), 840–848.
224. Crampin, AC, Dube, A, Mboma, S, et al. Profile: the Karonga Health and Demographic Surveillance System. Int J Epidemiol 41 (2012), 676–685.
225. Govindasamy, D, Kranzer, K, van Schaik, N, et al. Linkage to HIV, TB and non-communicable disease care from a mobile testing unit in Cape Town, South Africa. PLoS One, 8, 2013, e80017.
226. Haffner, SM, for the American Diabetes Association. Dyslipidemia management in adults with diabetes. Diabetes Care 27:suppl 1 (2004), S68–S71.
227. WHO. Package of essential noncommunicable (PEN) disease interventions for primary health care in low-resource settings. http://www.who.int/nmh/publications/essential_ncd_interventions_lr_settings.pdf, 2010 (accessed June 12, 2017).
228. Inzucchi, SE, Diabetes facts and guidelines: 2011, 2011, Yale Diabetes Centre, New Haven, CT.
229. Salomon, JA, Vos, T, Hogan, DR, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 380 (2012), 2129–2143.
230. Atun, RA, Lennox-Chhugani, N, Drobniewski, F, Samyshkin, YA, Coker, RJ, A framework and toolkit for capturing the communicable disease programmes within health systems: tuberculosis control as an illustrative example. Eur J Public Health 14 (2004), 267–273.
231. WHO. Making choices in health: WHO guide to cost-effectiveness analysis, 2003, World Health Organization, Geneva http://www.who.int/choice/publications/p_2003_generalised_cea.pdf (accessed June 10, 2017).
232. Kowal, P, Chatterji, S, Naidoo, N, et al. Data resource profile: the World Health Organization Study on global AGEing and adult health (SAGE). Int J Epidemiol 41 (2012), 1639–1649.
233. Atun, RA, Samyshkin, YA, Drobniewski, F, et al. Barriers to sustainable tuberculosis control in the Russian Federation health system. Bull World Health Organ 83 (2005), 217–223.
234. Shigayeva, A, Atun, R, McKee, M, Coker, R, Health systems, communicable diseases and integration. Health Policy Plan 25:suppl 1 (2010), i4–i20.
235. Atun, RA, McKee, M, Drobniewski, F, Coker, R, Analysis of how the health systems context shapes responses to the control of human immunodeficiency virus: case-studies from the Russian Federation. Bull World Health Organ 83 (2005), 730–738.
236. Atun, R, Lazarus, JV, Van Damme, W, Coker, R, Interactions between critical health system functions and HIV/AIDS, tuberculosis and malaria programmes. Health Policy Plan 25:suppl 1 (2010), i1–i3.
237. Jenkins, R, Lancashire, S, McDaid, D, et al. Mental health reform in the Russian Federation: an integrated approach to achieve social inclusion and recovery. Bull World Health Organ 85 (2007), 858–866.
238. Atun, R, Pothapregada, SK, Kwansah, J, Degbotse, D, Lazarus, JV, Critical interactions between the Global Fund-supported HIV programs and the health system in Ghana. J Acquir Immune Defic Syndr 57:suppl 2 (2011), S72–S76.
239. Unwin, N, Mugusi, F, Aspray, T, et al. Tackling the emerging pandemic of non-communicable diseases in sub-Saharan Africa: the essential NCD health intervention project. Public Health 113 (1999), 141–146.
240. Labhardt, ND, Balo, JR, Ndam, M, Manga, E, Stoll, B, Improved retention rates with low-cost interventions in hypertension and diabetes management in a rural African environment of nurse-led care: a cluster-randomised trial. Trop Med Int Health 16 (2011), 1276–1284.
241. Sobry, A, Kizito, W, Van den Bergh, R, et al. Caseload, management and treatment outcomes of patients with hypertension and/or diabetes mellitus in a primary health care programme in an informal setting. Trop Med Int Health 19 (2014), 47–57.
242. Watkins, PJ, Delivering care for diabetes in Ethiopia. Trans R Soc Trop Med Hyg 93 (1999), 355–356.
243. Mamo, Y, Seid, E, Adams, S, Gardiner, A, Parry, E, A primary healthcare approach to the management of chronic disease in Ethiopia: an example for other countries. Clin Med 7 (2007), 228–231.
244. Katz, I, Schneider, H, Shezi, Z, et al. Managing type 2 diabetes in Soweto—the South African Chronic Disease Outreach Program experience. Prim Care Diabetes 3 (2009), 157–164.
245. Distiller, LA, Brown, MA, Joffe, BI, Kramer, BD, Striving for the impossible dream: a community-based multi-practice collaborative model of diabetes management. Diabet Med 27 (2010), 197–202.
246. Gill, GV, Price, C, Shandu, D, Dedicoat, M, Wilkinson, D, An effective system of nurse-led diabetes care in rural Africa. Diabet Med 25 (2008), 606–611.
247. Price, C, Shandu, D, Dedicoat, M, Wilkinson, D, Gill, GV, Long-term glycaemic outcome of structured nurse-led diabetes care in rural Africa. QJM 104 (2011), 571–574.
248. Kengne, AP, Fezeu, L, Sobngwi, E, et al. Type 2 diabetes management in nurse-led primary healthcare settings in urban and rural Cameroon. Prim Care Diabetes 3 (2009), 181–188.
249. Ndou, T, van Zyl, G, Hlahane, S, Goudge, J, A rapid assessment of a community health worker pilot programme to improve the management of hypertension and diabetes in Emfuleni sub-district of Gauteng Province, South Africa. Glob Health Action, 6, 2013, 19228.
250. Joubert, PH, Sebata, PD, Bam, WJ, Skene, DJ, Home urinary glucose testing. Its impact on a third world diabetic population. S Afr Med J 65 (1984), 731–733.
251. Pastakia, SD, Karwa, R, Kahn, CB, Nyabundi, JS, The evolution of diabetes care in the rural, resource-constrained setting of western Kenya. Ann Pharmacother 45 (2011), 721–726.
252. Pastakia, SD, Ali, SM, Kamano, JH, et al. Screening for diabetes and hypertension in a rural low income setting in western Kenya utilizing home-based and community-based strategies. Global Health, 9, 2013, 21.
253. Gessler, N, Labhard, ND, Stolt, P, et al. The lesson of Monsieur Nouma: effects of a culturally sensitive communication tool to improve health-seeking behavior in rural Cameroon. Patient Educ Couns 87 (2012), 343–350.
254. van der Does, AMB, Mash, R, Evaluation of the “Take Five School”: an education programme for people with type 2 diabetes in the Western Cape, South Africa. Prim Care Diabetes 7 (2013), 289–295.
255. Mukama, LJ, Moran, A, Nyindo, M, Philemon, R, Msuya, L, Improved glycemic control and acute complications among children with type 1 diabetes mellitus in Moshi, Tanzania. Pediatr Diabetes 14 (2013), 211–216.
256. Windus, DW, Ladenson, JH, Merrins, CK, et al. Impact of a multidisciplinary intervention for diabetes in Eritrea. Clin Chem 53 (2007), 1954–1959.
257. Amoah, AGB, Owusu, SK, Acheampong, JW, et al. A national diabetes care and education programme: the Ghana model. Diabetes Res Clin Pract 49 (2000), 149–157.
258. MakkiAwouda, FO, Elmukashfi, TA, Hag Al-Tom, SA, Designing an educational and training program for diabetes health educators at Diabetic Health Centers, Khartoum State, Sudan; 2007–2010. Glob J Health Sci 5 (2013), 207–211.
259. Kouematchoua Tchuitcheu, G, Rienhoff, O, Options for diabetes management in sub-Saharan Africa with an electronic medical record system. Methods Inf Med 50 (2011), 11–22.
260. Steyn, K, Lombard, C, Gwebushe, N, et al. Implementation of national guidelines, incorporated within structured diabetes and hypertension records at primary level care in Cape Town, South Africa: a randomised controlled trial. Glob Health Action, 6, 2013, 20796.
261. Allain, TJ, van Oosterhout, JJ, Douglas, GP, et al. Applying lessons learnt from the ‘DOTS’ tuberculosis model to monitoring and evaluating persons with diabetes mellitus in Blantyre, Malawi. Trop Med Int Health 16 (2011), 1077–1084.
262. Chamie, G, Kwarisiima, D, Clark, TD, et al., for the SEARCH Collaboration. Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural Uganda. PLoS One, 7, 2012, e43400.
263. Goudge, J, Gilson, L, Russell, S, Gumede, T, Mills, A, Affordability, availability and acceptability barriers to health care for the chronically ill: longitudinal case studies from South Africa. BMC Health Serv Res, 9, 2009, 75.
264. Haque, M, Emerson, SH, Dennison, CR, Navsa, M, Levitt, NS, Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town. S Afr Med J 95 (2005), 798–802.
265. Hjelm, K, Atwine, F, Health-care seeking behaviour among persons with diabetes in Uganda: an interview study. BMC Int Health Hum Rights, 11, 2011, 11.
266. Kolling, M, Winkley, K, von Deden, M, “For someone who's rich, it's not a problem”. Insights from Tanzania on diabetes health-seeking and medical pluralism among Dar es Salaam's urban poor. Global Health, 6, 2010, 8.
267. Gill, GV, Yudkin, JS, Keen, H, Beran, D, The insulin dilemma in resource-limited countries. A way forward?. Diabetologia 54 (2011), 19–24.
268. Atun, R, Jaffar, S, Nishtar, S, et al. Improving responsiveness of health systems to non-communicable diseases. Lancet 381 (2013), 690–697.
269. Fraser, HSF, Allen, C, Bailey, C, Douglas, G, Shin, S, Blaya, J, Information systems for patient follow-up and chronic management of HIV and tuberculosis: a life-saving technology in resource-poor areas. J Med Internet Res, 9, 2007, e29.
270. Shiferaw, F, Zolfo, M, The role of information communication technology (ICT) towards universal health coverage: the first steps of a telemedicine project in Ethiopia. Glob Health Action 5 (2012), 1–8.
271. Kahn, JG, Yang, JS, Kahn, JS, ‘Mobile’ health needs and opportunities in developing countries. Health Aff 29 (2010), 252–258.
272. Chandrasekhar, CP, Ghosh, J, Information and communication technologies and health in low income countries: the potential and the constraints. Bull World Health Organ 79 (2001), 850–855.
273. Vodopivec-Jamsek, V, de Jongh, T, Gurol-Urganci, I, Atun, R, Car, J, Mobile phone messaging for preventive health care. Cochrane Database Syst Rev, 12, 2012 CD007457.
274. Gurol-Urganci, I, de Jongh, T, Vodopivec-Jamsek, V, Car, J, Atun, R, Mobile phone messaging for communicating results of medical investigations. Cochrane Database Syst Rev, 6, 2012 CD007456.
275. de Jongh, T, Gurol-Urganci, I, Vodopivec-Jamsek, V, Car, J, Atun, R, Mobile phone messaging telemedicine for facilitating self-management of long-term illnesses. Cochrane Database Syst Rev, 4, 2008 CD007459.
276. Car, J, Gurol-Urganci, I, de Jongh, T, Vodopivec-Jamsek, V, Atun, R, Mobile phone messaging reminders for attendance at healthcare appointments. Cochrane Database Syst Rev, 7, 2012 CD007458.
277. van Velthoven, MH, Tudor Car, L, Car, J, Atun, R, Telephone consultation for improving health of people living with or at risk of HIV: a systematic review. PLoS One, 7, 2012, e36105.
278. Palmer, JJ, Chinanayi, F, Gilbert, A, et al. Mapping human resources for eye health in 21 countries of sub-Saharan Africa: current progress towards VISION 2020. Hum Resour Health, 12, 2014, 44.
279. Hansen, MB, Abràmoff, MD, Folk, JC, Mathenge, W, Bastawrous, A, Peto, T, Results of automated retinal image analysis for detection of diabetic retinopathy from the Nakuru Study, Kenya. PLoS One, 10, 2015, e0139148.
280. Dyck, PJ, Overland, CJ, Low, PA, et al. Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs NPhys trial. Muscle Nerve 42 (2010), 157–164.
281. Atun, R, de Jongh, T, Secci, F, Ohiri, K, Adeyi, O, Integration of targeted health interventions into health systems: a conceptual framework for analysis. Health Policy Plan 25 (2010), 104–111.
282. Atun, R, Health systems, systems thinking and innovation. Health Policy Plan 27:suppl 4 (2012), iv4–iv8.
283. van Olmen, J, Schellevis, F, Van Damme, W, Kegels, G, Rasschaert, F, Management of chronic diseases in Sub-Saharan Africa: cross-fertilisation between HIV/AIDS and diabetes care. J Trop Med, 2012, 2012, 349312.
284. Schouten, EJ, Jahn, A, Midiani, D, et al. Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet 378 (2011), 282–284.
285. WHO. NCD global monitoring framework. http://www.who.int/nmh/global_monitoring_framework/en (accessed March 10, 2017).
286. Popkin, BM, Hawkes, C, Sweetening of the global diet, particularly beverages: patterns, trends, and policy responses. Lancet Diabetes Endocrinol 4 (2016), 174–186.
287. PSI. Why PSI uses social marketing: the evidence base, 2011, Population Sciences International, Washington, DC http://www.psi.org/wp-content/uploads/drupal/sites/default/files/publication_files/SM-Evidence-Base_March2011-update.pdf (accessed June 12, 2017).
288. Mauer, M, Zinman, B, Gardiner, R, et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 361 (2009), 40–51.
289. UN. Declaration of commitment on HIV/AIDS. “Global crisis—global action”. http://www.un.org/ga/aids/coverage/FinalDeclarationHIVAIDS.html (accessed March 10, 2017).
290. UN. Political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases. http://www.un.org/ga/search/view_doc.asp?symbol=A/66/L.1, 2011 (accessed March 10, 2017).
291. Swinburn, BA, Sacks, G, Hall, KD, et al. The global obesity pandemic: shaped by global drivers and local environments. Lancet 378 (2011), 804–814.
292. UN. Resolution adopted by the General Assembly on 13 May 2010. 64/265. Prevention and control of non-communicable diseases. http://www.un.org/en/ga/search/view_doc.asp?symbol=A/RES/64/265&Lang=E, 2010 (accessed March 10, 2017).
293. WHO. Sixty-fifth World Health Assembly. Second report of Committee A. http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_54-en.pdf (accessed March 10, 2017).
294. Atun, R, Decisive action to end apathy and achieve 25 × 25 NCD targets. Lancet 384 (2014), 384–385.
295. Moon, S, Sridhar, D, Pate, MA, et al. Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola. Lancet 386 (2015), 2204–2221.
296. Jobanputra, K, Boulle, P, Roberts, B, Perel, P, Three steps to improve management of noncommunicable diseases in humanitarian crises. PLoS Med, 13, 2016, e1002180.
297. Evans, T, Nishtar, S, Atun, R, Etienne, C, Scaling up research and learning for health systems: time to act. Lancet 372 (2008), 1529–1531.
298. Beran, D, Byass, P, Gbakima, A, et al. Research capacity building—obligations for global health partners. Lancet Glob Health 5 (2017), e567–e568.
299. George, PP, Papachristou, N, Belisario, JM, et al. Online eLearning for undergraduates in health professions: a systematic review of the impact on knowledge, skills, attitudes and satisfaction. J Glob Health, 4, 2014, 010406.
300. de Jongh, T, Gurol-Urganci, I, Vodopivec-Jamsek, V, Car, J, Atun, R, Mobile phone messaging for facilitating self-management of long-term illnesses. Cochrane Database Syst Rev, 12, 2012 CD007459.
301. Atun, R, Knaul, FM, Akachi, Y, Frenk, J, Innovative financing for health: what is truly innovative?. Lancet 380 (2012), 2044–2049.
302. Atun, R, Silva, S, Ncube, M, Vassall, A, Innovative financing for HIV response in sub-Saharan Africa. J Glob Health, 6, 2016, 010407.
303. Fitchett, JR, Fan Li, J, Atun, R, Innovative financing for late-stage global health research and development: the Global Health Investment Fund. Int Health 8 (2016), 3–4.